Did you know that base editing can be used for downregulation or activation of genes and making disease-specific SNV corrections, while helping to avoid potentially dangerous double strand DNA breaks?

In this recorded LinkedIn Live event, we dive into the world of gene editing and the potential of base editing. We also explore how our Pin-point™ base editing platform can provide precise and customizable genetic modifications, transforming genome engineering.

Key topics:

• Safety first: Discussion on safety in genetic engineering, comparing base editing with traditional CRISPR-Cas9 methods.
• Real-world applications: Hear how base editing can support reducing complex CAR-T cell engineering workflows by providing simultaneous multi-gene knockout and CAR insertion in a single intervention.
• Understand the Pin-point base editing platform: Learn the basics and why it's a potential game-changer in gene editing.

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.